Clinically, RAR agonists like tretinoin and isotretinoin are used for treating acne and psoriasis, while RAR-targeting agents are employed in the treatment of acute promyelocytic leukemia to induce differentiation of leukemic cells [51]. Here, RARA is linked to psoriasis.